The lncRNA BORG: a novel inducer of TNBC metastasis, chemoresistance, and disease recurrence

Abstract

Although greater than 90% of breast cancer-related mortality can be attributed to metastases, the molecular mechanisms underpinning the dissemination of primary breast tumor cells and their ability to establish malignant lesions in distant tissues remain incompletely understood. Genomic and transcriptomic analyses identified a class of transcripts called long noncoding RNA (lncRNA), which interact both directly and indirectly with key components of gene regulatory networks to alter cell proliferation, invasion, and metastasis. We identified a pro-metastatic lncRNA BMP/OP-Responsive Gene (BORG) whose aberrant expression promotes metastatic relapse by reactivating proliferative programs in dormant disseminated tumor cells (DTCs). BORG expression is broadly and strongly induced by environmental and chemotherapeutic stresses, a transcriptional response that facilitates the survival of DTCs. Transcriptomic reprogramming in response to BORG resulted in robust signaling via survival and viability pathways, as well as decreased activation of cell death pathways. As such, BORG expression acts as a (1) marker capable of predicting which breast cancer patients are predisposed to develop secondary metastatic lesions; and (2) unique therapeutic target to maximize chemosensitivity of DTCs. Here we review the molecular and cellular factors that contribute to the pathophysiological activities of BORG during its regulation of breast cancer metastasis, chemoresistance, and disease recurrence.

Keywords

BORG / chemoresistance / disease recurrence / dormancy / long noncoding RNA / metastasis / triple-negative breast cancer

References

[1] Siegel RL,Jemal A.Cancer statistics, 2018..CA Cancer J Clin2019;69:7-34

[2] Welch HG,O'Malley AJ.Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness..N Engl J Med2016;375:1438-47

[3] Arendt LM.Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy..J Mammary Gland Biol Neoplasia2015;20:9-25 PMCID:PMC4596764

[4] Gingras I,de Azambuja E.HER2-positive breast cancer is lost in translation: time for patient-centered research..Nat Rev Clin Oncol2017;14:669-81

[5] Payne SJ,Jones JL.Predictive markers in breast cancer--the present..Histopathology2008;52:82-90

[6] Anders CK.Biology, metastatic patterns, and treatment of patients with triple- negative breast cancer..Clin Breast Cancer2009;9:S73-81 PMCID:PMC2919761

[7] Costa RLB.Triple-negative breast cancer: current practice and future directions..J Oncol Pract2017;13:301-3

[8] Nguyen DX.Genetic determinants of cancer metastasis..Nat Rev Genet2007;8:341-52

[9] Gupta GP.Cancer metastasis: building a framework..Cell2006;127:679-95

[10] Dent R,Pritchard KI,Kahn HK.Triple-negative breast cancer: clinical features and patterns of recurrence..Clin Cancer Res2007;13:4429-34

[11] Pantel K.Dissecting the metastatic cascade..Nat Rev Cancer2004;4:448-56

[12] Vanharanta S.Origins of metastatic traits..Cancer Cell2013;24:410-21 PMCID:PMC3998120

[13] Stott SL,Nagrath S,Miyamoto DT.Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer..Sci Transl Med2010;2:25ra23 PMCID:PMC3141292

[14] Nagrath S,Maheswaran S,Irimia D.Isolation of rare circulating tumour cells in cancer patients by microchip technology..Nature2007;450:1235-9 PMCID:PMC3090667

[15] Luzzi KJ,Schmidt EE,Morris VL.Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases..Am J Pathol1998;153:865-73 PMCID:PMC1853000

[16] Hosseini H,Hoffmann M,Sosa MS.Early dissemination seeds metastasis in breast cancer..Nature2016;540:552-8 PMCID:PMC5390864

[17] Sosa MS,Aguirre-Ghiso JA.Mechanisms of disseminated cancer cell dormancy: an awakening field..Nat Rev Cancer2014;14:611-22 PMCID:PMC4230700

[18] van 't Veer LJ,van de Vijver MJ,Hart AA.Gene expression profiling predicts clinical outcome of breast cancer..Nature2002;415:530-6

[19] Hartkopf AD,Wallwiener M,Becker S.Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis..Eur J Cancer2014;50:2550-9

[20] Aguirre-Ghiso JA.Models, mechanisms and clinical evidence for cancer dormancy..Nat Rev Cancer2007;7:834-46 PMCID:PMC2519109

[21] MacKie RM,Junor B.Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery..N Engl J Med2003;348:567-8

[22] Ghajar CM,Mori H,Evason KJ.The perivascular niche regulates breast tumour dormancy..Nat Cell Biol2013;15:807-17 PMCID:PMC3826912

[23] Holmgren L,Folkman J.Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression..Nature medicine1995;1:149-53

[24] Shibue T.Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs..Proc Natl Acad Sci U S A2009;106:10290-5 PMCID:PMC2700942

[25] Shibue T,Inan MF,Weinberg RA.The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions..Cancer Discov2012;2:706-21 PMCID:PMC3418422

[26] Karrison TG,Meier P.Dormancy of mammary carcinoma after mastectomy..J Natl Cancer Inst2000;92:1101A-101

[27] Klein CA.Framework models of tumor dormancy from patient-derived observations..Curr Opin Genet Dev2011;21:42-9

[28] Demicheli R,Hrushesky WJ.Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures..Nat Clin Pract Oncol2007;4:699-710

[29] Rak JW,Miller FR.Sequential alteration of peanut agglutinin binding- glycoprotein expression during progression of murine mammary neoplasia..Br J Cancer1992;65:641-8 PMCID:PMC1977372

[30] Morris VL,Wilson SM,Chambers AF.Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines..Clin Exp Metastasis1993;11:103-12

[31] Morris VL,MacDonald IC,Grattan M.Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth..Clin Exp Metastasis1994;12:357-67

[32] Naumov GN,Weinmeister PM,Nadkarni KV.Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy..Cancer Res2002;62:2162-8

[33] De Cock JM,Dongre A,Reinhardt F.Inflammation triggers zeb-dependent escape from tumor latency..Cancer Res2016;76:6778-84 PMCID:PMC5135644

[34] Vera-Ramirez L,Nini R,Green JE.Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence..Nat Commun2018;9:1944 PMCID:PMC5964069

[35] Albrengues J,Ng D,Ambrico A.Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice..Science2018;361:pii:eaao4227

[36] Rinn JL.Genome regulation by long noncoding RNAs..Annu Rev Biochem2012;81:145-66 PMCID:PMC3858397

[37] Djebali S,Merkel A,Lassmann T.Landscape of transcription in human cells..Nature2012;489:101-8 PMCID:PMC3684276

[38] Ponting CP,Reik W.Evolution and functions of long noncoding RNAs..Cell2009;136:629-41

[39] Mattick JS,Faulkner GJ.A global view of genomic information--moving beyond the gene and the master regulator..Trends Genet2010;26:21-8

[40] Fatica A.Long non-coding RNAs: new players in cell differentiation and development..Nat Rev Genet2014;15:7-21

[41] Guttman M.Modular regulatory principles of large non-coding RNAs..Nature2012;482:339-46 PMCID:PMC4197003

[42] Huarte M.The emerging role of lncRNAs in cancer..Nat Med2015;21:1253-61

[43] Cabanski CR,Dang HX,Rauck CE.Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function..RNA Biol2015;12:628-42 PMCID:PMC4615893

[44] Iyer MK,Malik R,Sahu A.The landscape of long noncoding RNAs in the human transcriptome..Nat Genet2015;47:199-208 PMCID:PMC4417758

[45] Jiang YZ,Xu XE,Hu X.Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value..Cancer Res2016;76:2105-14

[46] Hah N,Core L,Siepel A.A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells..Cell2011;145:622-34 PMCID:PMC3099127

[47] Bhan A,Ansari KI,Bashyal A.Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol..J Mol Biol2013;425:3707-22 PMCID:PMC3679254

[48] Gupta RA,Wang KC,Horlings HM.Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis..Nature2010;464:1071-6 PMCID:PMC3049919

[49] Richard JLC.Deciphering the roles of lncRNAs in breast development and disease..Oncotarget2018;9:20179-212 PMCID:PMC5929455

[50] Takeda K,Fujii M,Saitoh M.Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA..J Biol Chem1998;273:17079-85

[51] Zhang B,Niazi F,Chen X.A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA..Mol Cell Biol2014;34:2318-29 PMCID:PMC4054287

[52] Derrien T,Bussotti G,Djebali S.The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression..Genome Res2012;22:1775-89 PMCID:PMC3431493

[53] Geisler S.RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts..Nat Rev Mol Cell Biol2013;14:699-712 PMCID:PMC4852478

[54] Mercer TR.Structure and function of long noncoding RNAs in epigenetic regulation..Nat Struct Mol Biol2013;20:300-7

[55] Kopp F.Functional classification and experimental dissection of long noncoding RNAs..Cell2018;172:393-407 PMCID:PMC5978744

[56] Gooding AJ,Gunawardane L,Valadkhan S.The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers..Oncogene2019;38:2020-41 PMCID:PMC6430670

[57] Gooding AJ,Jahanbani FK,Chang JC.The lncRNA BORG drives breast cancer metastasis and disease recurrence..Sci Rep2017;7:12698 PMCID:PMC5629202

[58] Li X,Jeng JC,Schultz DC.Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression..The Journal of biological chemistry2007;282:36177-89

[59] Lee YK,Yang AJ.Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells..J Biol Chem2007;282:1595-606

[60] Addison J,Fugett JH,Chen D.KAP1 promotes proliferation and metastatic progression of breast cancer cells..Cancer Res2015;75:344-55 PMCID:PMC4297582

[61] Calderon MR,Benslama RO,Bouttier M.Ligand-dependent corepressor contributes to transcriptional repression by C2H2 zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1..Nucleic Acids Res2014;42:7012-27 PMCID:PMC4066800

[62] Deb M,Sengupta D,Parbin S.Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer..Cell Mol Life Sci2014;71:3439-63

[63] Bunch H,Burkholder A,Motola S.TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release..Nat Struct Mol Biol2014;21:876-83 PMCID:PMC4189995

[64] Hu G,Xu Q,Orkin SH.A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal..Genes Dev2009;23:837-48 PMCID:PMC2666338

[65] Batista PJ.Long noncoding RNAs: cellular address codes in development and disease..Cell2013;152:1298-307 PMCID:PMC3651923

[66] Iyengar S.KAP1 protein: an enigmatic master regulator of the genome..J Biol Chem2011;286:26267-76 PMCID:PMC3143589

[67] Crea F,Farrar WL.Cancer stem cell epigenetics and chemoresistance..Epigenomics2009;1:63-79

[68] Quintieri L,Vizler C.Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs..Adv Exp Med Biol2007;593:95-104

[69] Dalton WS.The tumor microenvironment as a determinant of drug response and resistance..Drug Resist Updat1999;2:285-8

[70] Hazlehurst LA,Dalton WS.Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death..Oncogene2003;22:7396-402

[71] Naumov GN,MacDonald IC,Bramwell VH.Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases..Breast Cancer Res Treat2003;82:199-206

[72] Ranganathan AC,Zhang L.Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells?.Cancer Biol Ther2006;5:729-35 PMCID:PMC2516910

[73] Dai Y,Tang J,Luo Z.Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress..Oncotarget2016;7:25478-92 PMCID:PMC5041919

[74] Kleffel S.Tumor dormancy and cancer stem cells: two sides of the same coin?.Adv Exp Med Biol2013;734:145-79

[75] Zhao M,Guo X,Zhou X.PCAF/GCN5-mediated acetylation of RPA1 promotes nucleotide excision repair..Cell Rep2017;20:1997-2009

[76] Haring SJ,Binz SK.Cellular functions of human RPA1. Multiple roles of domains in replication, repair, and checkpoints..J Biol Chem2008;283:19095-111 PMCID:PMC2441558

[77] Baral E.In vitro effect of doxorubicin on non-proliferating and proliferating epithelial cells..Int J Radiat Oncol Biol Phys1990;19:963-5

[78] Li S,Payne S,Seewaldt VL.Model of tumor dormancy/recurrence after short-term chemotherapy..PLoS One2014;9:e98021 PMCID:PMC4028269

[79] Ribeiro DM,Cipriano A,Spinelli L.Protein complex scaffolding predicted as a prevalent function of long non-coding RNAs..Nucleic Acids Res2018;46:917-28 PMCID:PMC5778612

[80] Bochkareva E,Lees-Miller SP.Structure of the RPA trimerization core and its role in the multistep DNA-binding mechanism of RPA..EMBO J2002;21:1855-63 PMCID:PMC125950

[81] Wong JM,Ingles CJ.Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2..Oncogene2003;22:28-33

[82] Romanova LY,Blagosklonny MV.The interaction of p53 with replication protein A mediates suppression of homologous recombination..Oncogene2004;23:9025-33

[83] Li L,Peterson CA.An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair..Mol Cell Biol1995;15:5396-402 PMCID:PMC230789

[84] Wang T,Li JJ.The role of NF-kappaB in the regulation of cell stress responses..Int Immunopharmacol2002;2:1509-20

[85] Mercurio F.NF-kappaB as a primary regulator of the stress response..Oncogene1999;18:6163-71

[86] Hoesel B.The complexity of NF-kappaB signaling in inflammation and cancer..Mol Cancer2013;12:86 PMCID:PMC3750319

[87] Hayden MS.NF-kappaB, the first quarter-century: remarkable progress and outstanding questions..Genes Dev2012;26:203-34 PMCID:PMC3278889

[88] Godwin P,Heavey S,O'Byrne KJ.Targeting nuclear factor-kappa B to overcome resistance to chemotherapy..Front Oncol2013;3:120 PMCID:PMC3655421

[89] Montagut C,Ferrer B,Bellosillo B.Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients..Endocr Relat Cancer2006;13:607-16

[90] Liu H,Prescher JA,Qian D.Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models..Proc Natl Acad Sci U S A2010;107:18115-20 PMCID:PMC2964232

[91] Pece S,Confalonieri S,Vecchi M.Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content..Cell2010;140:62-73

[92] Louie E,Chen JS,Song B.Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation..Breast Cancer Res2010;12:R94 PMCID:PMC3046435

[93] Dongre A.New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer..Nat Rev Mol Cell Biol2019;20:69-84

[94] Li F,Massague J.Beyond tumorigenesis: cancer stem cells in metastasis..Cell Res2007;17:3-14

[95] Prager BC,Bao S.Cancer stem cells: the architects of the tumor ecosystem..Cell Stem Cell2019;24:41-53 PMCID:PMC6350931

[96] Schatton T,Frank MH.Identification and targeting of cancer stem cells..Bioessays2009;31:1038-49 PMCID:PMC2887758

[97] Jaksch M,Bajpai R,Oshima RG.Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines..Cancer Res2008;68:7882-6 PMCID:PMC2561223

[98] Velasco-Velazquez MA,Lisanti MP.The role of breast cancer stem cells in metastasis and therapeutic implications..Am J Pathol2011;179:2-11 PMCID:PMC3123864

[99] Sin WC.Breast cancer stem cells-from origins to targeted therapy..Stem Cell Investig2017;4:96 PMCID:PMC5723743

[100] Zhou M,Yang G,Tu G.LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway..Stem Cells2016;34:55-66 PMCID:PMC4832137

[101] Padua Alves C,Muys BR,Burger MC.Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines..Stem Cells2013;31:2827-32

[102] Chen YM,Wei HY,Fu P.Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells..Tumour Biol2016;37:10861-70

[103] Chen S,Wang F,Ge Y.LncRNAs and their role in cancer stem cells..Oncotarget2017;8:110685-92 PMCID:PMC5746414

[104] Mani SA,Liao MJ,Ayyanan A.The epithelial-mesenchymal transition generates cells with properties of stem cells..Cell2008;133:704-15 PMCID:PMC2728032

[105] Valadkhan S.lncRNAs in stress response..Curr Top Microbiol Immunol2016;394:203-36

[106] Piva R,Santoro MG.NF-kappaB: a stress-regulated switch for cell survival..Antioxid Redox Signal2006;8:478-86

[107] Kroger C,Mraz J,Reinhardt F.Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells..Proc Natl Acad Sci U S A2019;116:7353-62 PMCID:PMC6462070